Category: isoquinoline

3382-18-1, The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.3382-18-1, Name is 6,7-Dimethoxy-3,4-dihydroisoquinoline, molecular formula is C11H13NO2. In a Article, authors is Sadhu, Partha Sarathi£¬once mentioned of 3382-18-1

Synthesis of new praziquantel analogues: Potential candidates for the treatment of schistosomiasis

An efficient synthesis of antischistosomal drug praziquantel and analogues was achieved and the synthetic route designed was to afford structurally diverse analogues for better structure-activity relationship understanding. Total of nineteen PZQ analogues with structural variations at amide, piperazine and aromatic moieties have been synthesized and fully characterized. Among all the new analogues tested for antischistosomal activity, one dimethoxy tetrahydroisoquinoline analogue and two tetrahydro-beta-carboline analogues exhibited moderate activity against adult Schistosoma mansoni. Tetrahydro-beta-carboline analogues showed moderate activity whereas the presence of p-trifluoromethylbenzoyl and p-toluenesulphonyl moieties resulted in complete suppression of antischistosomal activity.

A reaction mechanism is the microscopic path by which reactants are transformed into products. Each step is an elementary reaction. In my other articles, you can also check out more blogs about 3382-18-1

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

19493-44-8, Because a catalyst decreases the height of the energy barrier, its presence increases the reaction rates of both the forward and the reverse reactions by the same amount.19493-44-8, Name is 1-Chloroisoquinoline, molecular formula is C9H6ClN. In a article£¬once mentioned of 19493-44-8

Design and optimisation of potent gp120-CD4 inhibitors

The synthesis and structure-activity relationship of a series of novel gp120-CD4 inhibitors are described. Pharmacokinetic studies and antiviral spectrum assessment of lead compounds led to the identification of compound 36, a potent gp120-CD4 inhibitor which exhibited antiviral potency across a spectrum of 25 clade B isolates.

A reaction mechanism is the microscopic path by which reactants are transformed into products. Each step is an elementary reaction. 19493-44-8, In my other articles, you can also check out more blogs about 19493-44-8

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

Chemistry is traditionally divided into organic and inorganic chemistry. 201150-73-4, The former is the study of compounds containing at least one carbon-hydrogen bonds.In a patent£¬Which mentioned a new discovery about 201150-73-4

A taxol and […] ketone BTK inhibitor combination pharmaceutical composition and its application (by machine translation)

The present invention provides a taxol and […] ketone BTK inhibitor combination pharmaceutical composition comprising an active ingredient and a pharmaceutically acceptable auxiliary material, wherein the active ingredient by the taxol of formula (I) of a BTK inhibitors shown, the active ingredient of taxol in the formula (I) indicated by the molar ratio of BTK inhibitors (0.14 – 0.20): 1. The pharmaceutical composition can be used for preparing the prevention and/or treating the Bruton tyrosine kinase-related disease drug, the treatment effect is good. (by machine translation)

Enzymes are biological catalysts that produce large increases in reaction rates and tend to be specific for certain reactants and products. I hope my blog about is helpful to your research. 201150-73-4

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In some cases, the catalyzed mechanism may include additional steps.In a article, 215184-78-4, molcular formula is C14H18BrNO2, introducing its new discovery. 215184-78-4

GPR40 receptor agonists, methods of making and pharmaceutical compositions and uses thereof (by machine translation)

The invention discloses a GPR40 receptor agonist, a preparation method and a pharmaceutical composition and application thereof. The invention specifically discloses a GPR40 receptor agonist shown by general formula (I) and a pharmaceutically acceptable salt thereof, a preparation process of the compound, a pharmaceutical composition containing the compound of the general formula (I), and an application of the compound and the pharmaceutical composition in the anti-diabetic direction. (by machine translation)

Because enzymes can increase reaction rates by enormous factors and tend to be very specific, 215184-78-4, typically producing only a single product in quantitative yield, they are the focus of active research.you can also check out more blogs about 215184-78-4

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

Chemistry is the science of change. But why do chemical reactions take place? Why do chemicals react with each other? The answer is in thermodynamics and kinetics.In a document type is Article, the author is Fleming, Cassandra L. and a compound is mentioned, 423146-25-2, 6-(6-Morpholino-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)hexanoic acid, introducing its new discovery. 423146-25-2

A fluorescent histone deacetylase (HDAC) inhibitor for cellular imaging

Fluorescence microscopy studies using 4-morpholinoscriptaid (4MS) demonstrated rapid cellular uptake of this scriptaid analogue into the cytoplasm but no nuclear penetration. As 4MS and scriptaid have the same in vitro activity against HDACs and KASUMI-1 cells; 4MS exemplifies a rational approach to subtly modify ‘profluorogenic’ substrates for intracellular studies.

Interested yet? Keep reading other articles of 189028-93-1!, 423146-25-2

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

129075-56-5, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 129075-56-5, name is 5-Methyl-3,4-dihydroisoquinolin-1(2H)-one, introducing its new discovery.

Inhibitors of PARPs that catalyze mono-ADP-ribosylation

Provided herein are compounds of Formula I, or a pharmaceutically acceptable salt thereof: which are useful as PARP inhibitors, as well as pharmaceutical compositions comprising them and methods for their use in treating disorders.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.129075-56-5, you can also check out more blogs about129075-56-5

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

1532-71-4, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In a patent, 1532-71-4, molecular formula is C9H6BrN, introducing its new discovery.

A pharmaceutical intermediate diaryl ketone compound synthesis method (by machine translation)

The invention relates to a can be useful as pharmaceutical intermediates of the formula shown in (III) of the method for synthesis of aryl ketone compound, said method comprising: in the nitrogen atmosphere and in organic solvent, in catalyst, oxidizing agent, in the presence of alkali and accelerant, the following formula (I) compounds and the following formula (II) compound generating reaction, after-treatment after reaction, so as to obtain the compound of said formula (III), wherein R 1-R 3 each independently selected from H, C 1-C 6 alkyl, C 1-C 6 alkoxy, halogen or nitro; X is halogen. The stated method, through appropriate selection of the substrate, and a catalyst is used, the oxidizing agent, alkali, accelerator and a reaction of the components of the organic solvent system, which can obtain the target product with high yield, for the kind of compound provides a new synthesis method, it has broad market application prospects. (by machine translation)

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.1532-71-4, you can also check out more blogs about1532-71-4

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

Let¡¯s face it, organic chemistry can seem difficult to learn. Especially from a beginner¡¯s point of view. Like 486-73-7, Name is Isoquinoline-1-carboxylic acid. In a document type is Article, introducing its new discovery., 486-73-7

Synthesis and structure-activity relationships of potential anticonvulsants based on 2-piperidinecarboxylic acid and related pharmacophores

Using N-(2,6-dimethyl)phenyl-2-piperidinecarboxamide (1) and N-(alpha-methylbenzyl)-2-piperidinecarboxamide (2) as structural leads, a variety of analogues were synthesised and evaluated for anticonvulsant activity in the MES test in mice. In the N-benzyl series, introduction of 3-Cl, 4-Cl, 3,4-Cl2, or 3-CF3 groups on the aromatic ring led to an increase in MES activity. Replacement of the alpha-methyl group by either i-Pr or benzyl groups enhanced MES activity with no increase in neurotoxicity. Substitution on the piperidine ring nitrogen led to a decrease in MES activity and neurotoxicity, while reduction of the amide carbonyl led to a complete loss of activity. Movement of the carboxamide group to either the 3- or 4-positions of the piperidine ring decreased MES activity and neurotoxicity. Incorporation of the piperidine ring into a tetrahydroisoquinoline or diazahydrinone nucleus led to increased neurotoxicity. In the N-(2,6-dimethyl)phenyl series, opening of the piperidine ring between the 1- and 6-positions gave the active norleucine derivative 75 (ED50 = 5.8 mg kg-1, TD50 = 36.4 mg kg-1, PI = 6.3). Replacement of the piperidine ring of 1 by cycloalkane (cyclohexane, cyclopentane, and cyclobutane) resulted in compounds with decreased MES activity and neurotoxicity, whereas replacement of the piperidine ring by a 4-pyridyl group led to a retention of MES activity with a comparable PI. Simplification of the 2-piperidinecarboxamide nucleus of 1 into a glycinecarboxamide nucleus led to about a six-fold decrease in MES activity. The 2,6-dimethylanilides were the most potent compounds in the MES test in each group of compounds evaluated, and compounds 50 and 75 should be useful leads in the development of agents for the treatment of tonic-clonic and partial seizures in man.

If you¡¯re interested in learning more about 3382-18-1, below is a message from the blog Manager. 486-73-7

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

Children learn through play, and they learn more than adults might expect. Science experiments are a great way to spark their curiosity, get their minds active, and encourage them to do something that doesn¡¯t involve a screen. 1532-72-5, C9H7NO. A document type is Article, introducing its new discovery., 1532-72-5

DEOXYGENATIVE 2-ALKOXYLATION OF QUINOLINE 1-OXIDE

Treatment of quinoline 1-oxide (1) with ethyl chloroformate or tosyl chloride and triethylamine in some lower alcohols affords the corresponding 2-alkoxyquinolines (2a-f) in generally satisfactory yields.Reactions of 2-methylpyridine and 2-methylquinoline 1-oxides lead to the corresponding 2-ethoxycarbonyloxymethyl (3 and 5) and 2-ethoxymethyl derivatives (4 and 6).

If you¡¯re interested in learning more about 165253-31-6, below is a message from the blog Manager. 1532-72-5

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 214045-84-8, name is 6-Fluoro-3,4-dihydroisoquinolin-1(2H)-one, introducing its new discovery. 214045-84-8

HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS

The invention relates to activators of FXR useful in the treatment of autoimmune disorders, liver disease, intestinal disease, kidney disease, cancer, and other diseases in which FXR plays a role, having the Formula (I): (I), wherein L1, A, X1, X2, R1, R2, and R3 are described herein.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.214045-84-8, you can also check out more blogs about214045-84-8

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem